A global initiative in innovating to assess treatment efficacy early in the process, improving patient care and outcomes. Wouldn’t it be wonderful if we could determine whether a treatment is working after just one cycle rather than having to wait for 3 or 4 cycles?...
For this global initiative to advance early cancer detection technologies, increasing treatment options and survival rates Inspire2Live started a social enterprise called OncoInv. Our partner in this is the Chinese/American company SeekIn. Through SeekIn we make our...
Local efforts to prioritise cancer care by identifying specific cancer challenges within countries, supported by accurate data collection and analysis. Local efforts to prioritize cancer care by identifying specific cancer challenges within countries, supported by...
A global lighthouse project providing personalized treatment plans by merging Whole Genome Sequencing with drug screening, focusing initially on glioblastoma and pancreatic cancer, but we will broaden the perspective. DEEP Diagnostics is an Inspire2Live lighthouse...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy
